Stephens Consulting, LLC 10x Genomics, Inc. Transaction History
Stephens Consulting, LLC
- $292 Billion
- Q3 2025
A detailed history of Stephens Consulting, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Stephens Consulting, LLC holds 21 shares of TXG stock, worth $261. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21
Previous 21
-0.0%
Holding current value
$261
Previous $244,000
0.82%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TXG
# of Institutions
339Shares Held
115MCall Options Held
442KPut Options Held
149K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13.9MShares$173 Million1.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$155 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$79.5 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.01MShares$74.8 Million0.74% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.38MShares$66.9 Million0.04% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.18B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...